3rd Quarter - Report

WALTER CONSULTING for AMERISOURCEBERGEN CORPORATION

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Implementation of the Patient Protection and Affordable Care Act of 2010 Pharmaceutical Distribution Reimbursement H.R. 905-- Excluding customary prompt pay discounts from ASP 3% withholding tax H.R. 674, S. 89, & S. 164. Pharmaceutical pedigree anti-counterfeiting legislation H.R. 1483, H.R. 3026, & S. 1584.

LobbyistCovered position, as disclosed
SARAH WALTER Former Legislative Director, Sen John Breaux

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1483 (112th), H.R. 905 (112th), S. 1584 (112th), H.R. 674 (112th), S. 89 (112th), H.R. 3026 (112th), S. 164 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.